These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14576845)

  • 21. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
    Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkylation damage in DNA and RNA--repair mechanisms and medical significance.
    Drabløs F; Feyzi E; Aas PA; Vaagbø CB; Kavli B; Bratlie MS; Peña-Diaz J; Otterlei M; Slupphaug G; Krokan HE
    DNA Repair (Amst); 2004 Nov; 3(11):1389-407. PubMed ID: 15380096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents.
    Rasmussen LJ; Rasmussen M; Lützen A; Bisgaard HC; Singh KK
    Exp Cell Res; 2000 May; 257(1):127-34. PubMed ID: 10854060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cadmium inhibits human DNA mismatch repair in vivo.
    Lützen A; Liberti SE; Rasmussen LJ
    Biochem Biophys Res Commun; 2004 Aug; 321(1):21-5. PubMed ID: 15358209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
    Kondo A; Safaei R; Mishima M; Niedner H; Lin X; Howell SB
    Cancer Res; 2001 Oct; 61(20):7603-7. PubMed ID: 11606400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of tolerance to DNA damaging therapeutic drugs.
    Karran P
    Carcinogenesis; 2001 Dec; 22(12):1931-7. PubMed ID: 11751422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of MMR plasmid substrates and analysis of MMR error correction and excision.
    Wang H; Hays JB
    Methods Mol Biol; 2006; 314():345-53. PubMed ID: 16673892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the DNA repair nucleases Rad13, Rad2 and Uve1 of Schizosaccharomyces pombe in mismatch correction.
    Kunz C; Fleck O
    J Mol Biol; 2001 Oct; 313(2):241-53. PubMed ID: 11800554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triazene compounds: mechanism of action and related DNA repair systems.
    Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
    Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mismatch repair].
    Goliasnaia NV; Tsvetkova NA
    Mol Biol (Mosk); 2006; 40(2):211-23. PubMed ID: 16637261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
    Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
    Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human pluripotent stem cells have a novel mismatch repair-dependent damage response.
    Lin B; Gupta D; Heinen CD
    J Biol Chem; 2014 Aug; 289(35):24314-24. PubMed ID: 25012654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
    Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
    Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrimination and versatility in mismatch repair.
    Hays JB; Hoffman PD; Wang H
    DNA Repair (Amst); 2005 Dec; 4(12):1463-74. PubMed ID: 16213799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
    Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
    Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+chromosome 3 cell line.
    Chauhan DP; Yang Q; Carethers JM; Marra G; Chang CL; Chamberlain SM; Boland CR
    Clin Cancer Res; 2000 Oct; 6(10):3827-31. PubMed ID: 11051225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA mismatch repair system. Classical and fresh roles.
    Jun SH; Kim TG; Ban C
    FEBS J; 2006 Apr; 273(8):1609-19. PubMed ID: 16623698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.